{
  "DOI": "10.1038/ejhg.2009.188",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.188",
  "alternative-id": [
    "BFejhg2009188"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Fernández-Fernández",
      "given": "Francisco José",
      "sequence": "first"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2009,
        11,
        4
      ]
    ],
    "date-time": "2009-11-04T11:24:20Z",
    "timestamp": 1257333860000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:58:16Z",
    "timestamp": 1684429096000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        5,
        19
      ]
    ],
    "date-time": "2023-05-19T04:30:58Z",
    "timestamp": 1684470658054
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2009,
        11,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            11,
            4
          ]
        ],
        "date-time": "2009-11-04T00:00:00Z",
        "timestamp": 1257292800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2009188.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009188",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009188.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "404-404",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        11,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        11,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/ejhg.2009.35",
      "author": "FS Govani",
      "doi-asserted-by": "publisher",
      "first-page": "860",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2009188_CR1",
      "unstructured": "Govani FS, Shovlin CL : Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009; 17: 860–871.",
      "volume": "17",
      "year": "2009"
    },
    {
      "DOI": "10.1159/000072411",
      "author": "A Cirulli",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Acta Haematol",
      "key": "BFejhg2009188_CR2",
      "unstructured": "Cirulli A, Liso A, D’Ovidio F et al: Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol 2003; 110: 29–32.",
      "volume": "110",
      "year": "2003"
    },
    {
      "DOI": "10.1002/lt.21417",
      "author": "A Mitchell",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Liver Transpl",
      "key": "BFejhg2009188_CR3",
      "unstructured": "Mitchell A, Adams LA, MacQuillan G, Tibballs J, vanden Driesen R, Delriviere L : Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 2008; 14: 210–213.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMc0901421",
      "author": "P Bose",
      "doi-asserted-by": "publisher",
      "first-page": "2143",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009188_CR4",
      "unstructured": "Bose P, Holter JL, Selby GB : Bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 2009; 360: 2143–2144.",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1002/lary.20159",
      "author": "J Simonds",
      "doi-asserted-by": "publisher",
      "first-page": "988",
      "journal-title": "Laryngoscope",
      "key": "BFejhg2009188_CR5",
      "unstructured": "Simonds J, Miller F, Mandel J, Davidson TM : The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 2009; 119: 988–992.",
      "volume": "119",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1365-2141.2009.07730.x",
      "author": "SJ Bowcock",
      "doi-asserted-by": "publisher",
      "first-page": "220",
      "journal-title": "Br J Haematol",
      "key": "BFejhg2009188_CR6",
      "unstructured": "Bowcock SJ, Patrick HE : Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Br J Haematol 2009; 146: 220–222.",
      "volume": "146",
      "year": "2009"
    },
    {
      "author": "EM de Gussem",
      "first-page": "85",
      "journal-title": "Rhinology",
      "key": "BFejhg2009188_CR7",
      "unstructured": "de Gussem EM, Snijder RJ, Disch FJ, Zanen P, Westermann CJ, Mager JJ : The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study. Rhinology 2009; 47: 85–88.",
      "volume": "47",
      "year": "2009"
    },
    {
      "author": "H Sadick",
      "first-page": "818",
      "journal-title": "Haematologica",
      "key": "BFejhg2009188_CR8",
      "unstructured": "Sadick H, Riedel F, Naim R et al: Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta 1 as well as high ALK1 tissue expression. Haematologica 2005; 90: 818–828.",
      "volume": "90",
      "year": "2005"
    },
    {
      "DOI": "10.1378/chest.124.5.2017",
      "author": "LC Ginns",
      "doi-asserted-by": "publisher",
      "first-page": "2017",
      "journal-title": "Chest",
      "key": "BFejhg2009188_CR9",
      "unstructured": "Ginns LC, Roberts DH, Mark EJ, Brusch JL, Marler JJ : Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline. Chest 2003; 124: 2017–2022.",
      "volume": "124",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJMc053410",
      "author": "MA Moses",
      "doi-asserted-by": "publisher",
      "first-page": "2621",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2009188_CR10",
      "unstructured": "Moses MA, Harper J, Folkman J : Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med 2006; 354: 2621–2622.",
      "volume": "354",
      "year": "2006"
    }
  ],
  "reference-count": 10,
  "references-count": 10,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2009188"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment"
  ],
  "type": "journal-article",
  "volume": "18"
}